Willis Towers Watson (WLTW) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
30 Apr, 2026Executive summary
Revenue rose 8% year-over-year to $2.41 billion, with 3% organic growth in Q1 2026 and adjusted operating margin of 22.3%; adjusted diluted EPS increased 19% to $3.72.
Net income attributable to shareholders was $303 million, up 27% year-over-year; diluted EPS reached $3.10, up 33%.
AI-enabled solutions, technology investments, and the integration of Newfront's AI-powered broking platform are scaling, driving efficiency and client outcomes.
$300 million in share repurchases and $88 million in dividends were returned to shareholders in Q1 2026.
Supported clients through macroeconomic volatility and executed strategic priorities amid challenging global markets, especially in the Middle East.
Financial highlights
Adjusted operating margin expanded by 70 bps year-over-year to 22.3%; adjusted EBITDA margin rose to 24.4%.
Adjusted diluted EPS grew 19% to $3.72; net income increased 27% to $303 million.
Free cash flow was -$65 million, a $21 million improvement year-over-year, reflecting margin expansion and lower transformation outflows.
Cash and cash equivalents at quarter-end were $1.9 billion, down from $3.1 billion at year-end 2025, mainly due to the Newfront acquisition and share repurchases.
Net cash from operating activities improved to -$10 million from -$35 million year-over-year.
Outlook and guidance
Maintains mid-single-digit organic growth and continued margin expansion guidance for 2026, with ~100 bps average annual margin expansion targeted in Risk & Broking.
Share repurchases of at least $1 billion planned for the year, subject to market conditions.
Newfront acquisition expected to be ~$0.10 dilutive to adjusted EPS in 2026, with $250 million post-close revenue and ~26% adjusted EBITDA margin.
Willis Re JV expected to be a ~$0.30 headwind to adjusted diluted EPS in 2026.
Foreign exchange expected to provide a ~$0.35 tailwind to adjusted diluted EPS for full year 2026.
Latest events from Willis Towers Watson
- Six major proposals, board refreshment, strong performance, and enhanced risk oversight highlighted.WLTW
Proxy filing27 Mar 2026 - Key votes include director elections, auditor ratification, and share plan amendments.WLTW
Proxy filing27 Mar 2026 - Organic growth and margin expansion drove strong results despite divestiture impacts.WLTW
Q4 20253 Feb 2026 - Q2 2024 delivered 6% organic growth, margin expansion, and raised 2024 guidance.WLTW
Q2 20242 Feb 2026 - Q3 saw 6% revenue growth, margin gains, and a $1.67B loss from TRANZACT sale charges.WLTW
Q3 202417 Jan 2026 - Sustained organic growth and margin expansion driven by innovation, efficiency, and portfolio optimization.WLTW
CMD 202412 Jan 2026 - 5% organic growth, margin gains, $473M savings, and $1.5B buyback planned for 2025.WLTW
Q4 20248 Jan 2026 - $1.3B acquisition leverages advanced tech and talent for $35M in synergies and U.S. growth.WLTW
M&A Announcement10 Dec 2025 - 2025 AGM to vote on directors, auditors, executive pay, share issuance, and pre-emption rights.WLTW
Proxy Filing1 Dec 2025